SCHEMBL3455672

SCHEMBL3455672

C1=C(c2ccc(N3CCOCC3)cc2)CNC(C2CCNCC2)=C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.39
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
MELK Q14680 1/20 0.37
JAK2 O60674 1/20 0.37
JAK3 P52333 1/20 0.37
SYK P43405 2/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
MYLK4 Q86YV6 1/20 0.35
STK17A Q9UEE5 1/20 0.35
ADRB1 P08588 2/20 0.35
ADRB2 P07550 1/20 0.35
NCF1 P14598 1/20 0.35
PLD1 Q13393 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3464719 0.83 MAPT (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL19139501 0.73 SIGMAR1 (0.48) LRRK2ADRB1HTR3EHTR3BHTR3A
SCHEMBL3067368 0.73 ALDH1A1 (0.35) LRRK2MELKSYKCHRM2CHRM4
SCHEMBL7082120 0.71 ADRB1 (0.63) ADRB1ADRB2NCF1PLD1HTR3E
SCHEMBL3454499 0.70 HTR6 (0.33) JAK2
SCHEMBL3065789 0.69 JAK2 (0.48) LRRK2MELKJAK2JAK3SYK
Hydrochloric Acid SCHEMBL28769210 0.69 ADRB1 (0.61) ADRB1ADRB2NCF1PLD1HTR3E
Bromide SCHEMBL6539744 0.69 ADRB1 (0.61) ADRB1ADRB2NCF1PLD1HTR3E
SCHEMBL10162461 0.68 HTR3A (0.53) JAK3HTR3AALDH1A1MEN1NPC1
SCHEMBL22324796 0.66 SIGMAR1 (0.45) MELKSIGMAR1PIK3CAALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2166850-A1 NEW HETEOCYCLIC H3 ANTAGONISTS High Point Pharmaceuticals, LLC (US) 2010-03-31 EP disclosed
WO-2008154126-A1 NEW HETEOCYCLIC H3 ANTAGONISTS HIGH POINT PHARMACEUTICALS, LLC (US) 2008-12-18 WO disclosed